
  
    
      
        Introduction_NNP
        The_DT knowledge_NN of_IN a_DT complete_JJ genome_NN sequence_NN holds_VBZ the_DT
        potential_NN to_TO reveal_VB the_DT '_POS blueprints_NNS '_POS for_IN cellular_JJ life_NN ._. The_DT
        genome_NN sequence_NN contains_VBZ the_DT information_NN to_TO propagate_NN the_DT
        living_VBG system_NN ,_, and_CC this_DT information_NN exists_VBZ as_IN open_JJ reading_NN
        frames_NNS (_( ORFs_NNP )_) and_CC regulatory_JJ information_NN ._. Computational_NNP
        approaches_NNS have_VBP been_VBN developed_VBN (_( and_CC are_VBP continuously_RB being_VBG
        improved_VBN )_) to_TO decipher_NN the_DT information_NN encoded_JJ in_IN the_DT DNA_NNP [_NN
        1_CD ,_, 2_CD ,_, 3_CD ,_, 4_CD ,_, 5_CD ,_, 6_CD ,_, 7_CD ]_NN ._. However_RB ,_, it_PRP is_VBZ becoming_VBG evident_JJ that_IN
        cellular_JJ functions_NNS are_VBP intricate_JJ and_CC the_DT integrated_VBN
        function_NN of_IN biological_JJ systems_NNS involves_VBZ many_JJ complex_JJ
        interactions_NNS among_IN the_DT molecular_JJ components_NNS within_IN the_DT
        cell_NN ._. To_TO understand_VB the_DT complexity_NN inherent_JJ in_IN cellular_JJ
        networks_NNS ,_, approaches_NNS that_WDT focus_VBP on_IN the_DT systemic_JJ properties_NNS
        of_IN the_DT network_NN are_VBP also_RB required_VBN ._.
        The_DT complexity_NN of_IN integrated_VBN cellular_JJ systems_NNS leads_VBZ to_TO
        an_DT important_JJ point_NN ,_, namely_RB that_IN the_DT properties_NNS of_IN complex_JJ
        biological_JJ processes_VBZ cannot_NN be_VB analyzed_VBN or_CC predicted_VBD based_VBN
        solely_RB on_IN a_DT description_NN of_IN the_DT individual_JJ components_NNS ,_, and_CC
        integrated_VBN systems_NNS based_VBD approaches_NNS must_MD be_VB applied_VBN [_NN 8_CD ]_NN ._.
        The_DT focus_NN of_IN such_JJ research_NN represents_VBZ a_DT departure_NN from_IN the_DT
        classical_JJ 
        reductionist_NN approach_NN in_IN the_DT
        biological_JJ sciences_NNS ,_, and_CC moves_NNS toward_IN the_DT 
        integrated_VBN approach_NN to_TO understanding_VBG
        the_DT interrelatedness_NNS of_IN gene_NN function_NN and_CC the_DT role_NN of_IN each_DT
        gene_NN in_IN the_DT context_NN of_IN multi_NN genetic_JJ cellular_JJ functions_NNS or_CC 
        genetic_JJ circuits_NNS [_NN 8_CD ,_, 9_CD ,_, 10_CD ]_NN ._.
        The_DT engineering_NN approach_NN to_TO analysis_NN and_CC design_NN of_IN
        complex_JJ systems_NNS is_VBZ to_TO have_VB a_DT mathematical_JJ or_CC computer_NN
        model_NN ;_: e_SYM ._. g_SYM ._. a_DT dynamic_JJ simulator_NN of_IN a_DT cellular_JJ process_NN that_WDT
        is_VBZ based_VBN on_IN fundamental_JJ physicochemical_JJ laws_NNS and_CC
        principles_NNS ._. Herein_NNP ,_, we_PRP will_MD analyze_VB the_DT integrated_VBN function_NN
        of_IN the_DT metabolic_JJ pathways_NNS ,_, and_CC there_EX has_VBZ been_VBN a_DT long_JJ
        history_NN of_IN mathematical_JJ modeling_NN of_IN metabolic_JJ networks_NNS in_IN
        cellular_JJ systems_NNS ,_, which_WDT dates_VBZ back_RB to_TO the_DT 1960_CD s_VBZ [_NN 11_CD ,_, 12_CD ]_NN ._.
        While_IN the_DT ultimate_JJ goal_NN is_VBZ the_DT development_NN of_IN dynamic_JJ
        models_NNS for_IN the_DT complete_JJ simulation_NN of_IN cellular_JJ metabolism_NN ,_,
        the_DT success_NN of_IN such_JJ approaches_NNS has_VBZ been_VBN severely_RB hampered_VBN
        by_IN the_DT lack_NN of_IN kinetic_JJ information_NN on_IN the_DT dynamics_NNS and_CC
        regulation_NN of_IN metabolism_NN ._. However_RB ,_, in_IN the_DT absence_NN of_IN
        kinetic_JJ information_NN it_PRP is_VBZ still_RB possible_JJ to_TO assess_VB the_DT
        theoretical_JJ capabilities_NNS and_CC operative_JJ modes_NNS of_IN metabolism_NN
        using_VBG flux_NN balance_NN analysis_NN (_( FBA_NNP )_) [_NN 10_CD ,_, 13_CD ,_, 14_CD ,_, 15_CD ,_, 16_CD ,_,
        17_CD ]_NN ._.
        We_PRP have_VBP developed_VBN an_DT 
        in_IN silico_NN representation_NN of_IN 
        Escherichia_NNP coli_NNS (_( E_NNP ._. coli_NNS in_IN
        silico_NN )_) to_TO describe_VB the_DT bacterium_NN 's_POS metabolic_JJ
        capabilities_NNS [_NN 18_CD ]_NN ._. 
        E_NNP ._. coli_NNS in_IN silico_NN was_VBD derived_VBN based_VBN
        on_IN the_DT annotated_JJ genetic_JJ sequence_NN [_NN 19_CD ]_NN ,_, biochemical_JJ
        literature_NN [_NN 20_CD ]_NN ,_, and_CC the_DT online_NN bioinformatic_JJ databases_NNS [_NN
        21_CD ,_, 22_CD ,_, 23_CD ]_NN ._. The_DT properties_NNS of_IN 
        E_NNP ._. coli_NNS in_IN silico_NN were_VBD analyzed_VBN and_CC
        compared_VBN to_TO the_DT 
        in_IN vivo_NN properties_NNS of_IN 
        E_NNP ._. coli_NNS ,_, and_CC it_PRP was_VBD shown_VBN that_IN 
        E_NNP ._. coli_NNS in_IN silico_NN can_MD be_VB used_VBN to_TO
        interpret_VB the_DT metabolic_JJ phenotype_NN of_IN many_JJ 
        E_NNP ._. coli_NNS mutants_NNS [_NN 18_CD ]_NN ._. However_RB ,_, the_DT
        utilization_NN of_IN the_DT metabolic_JJ genes_NNS is_VBZ dependent_JJ on_IN the_DT
        carbon_NN source_NN and_CC the_DT substrate_NN availability_NN [_NN 24_CD ,_, 25_CD ]_NN ._.
        Thus_RB ,_, the_DT mutant_JJ phenotype_NN is_VBZ also_RB dependent_JJ on_IN specific_JJ
        environmental_JJ parameters_NNS ._. Therefore_RB ,_, herein_NN we_PRP have_VBP
        utilized_JJ 
        E_NNP ._. coli_NNS in_IN silico_NN to_TO computationally_RB
        examine_VB the_DT condition_NN dependent_JJ optimal_NN metabolic_JJ pathway_NN
        utilization_NN ,_, and_CC we_PRP will_MD show_VB that_IN the_DT FBA_NNP can_MD be_VB used_VBN to_TO
        analyze_VB and_CC interpret_VB the_DT metabolic_JJ behavior_NN of_IN wildtype_NN
        and_CC mutant_JJ 
        E_NNP ._. coli_NNS strains_NNS ._.
      
      
        Materials_NNS and_CC Methods_NNP
        
          Flux_NNP balance_NN analysis_NN
          All_DT biological_JJ processes_NNS are_VBP subjected_VBN to_TO physico_NN
          chemical_NN constraints_NNS (_( such_JJ as_IN mass_NN balance_NN ,_, osmotic_JJ
          pressure_NN ,_, electro_NN neutrality_NN ,_, thermodynamic_JJ ,_, and_CC other_JJ
          constraints_NNS )_) ._. As_IN a_DT result_NN of_IN decades_NNS of_IN metabolic_JJ
          research_NN and_CC the_DT recent_JJ genome_NN sequencing_VBG projects_NNS ,_, the_DT
          mass_NN balance_NN constraints_NNS on_IN cellular_JJ metabolism_NN can_MD be_VB
          assigned_VBN on_IN a_DT genome_NN scale_NN for_IN a_DT number_NN of_IN organisms_NNS ._.
          Methods_NNP have_VBP been_VBN developed_VBN to_TO analyze_VB the_DT metabolic_JJ
          capabilities_NNS of_IN a_DT cellular_JJ system_NN based_VBN on_IN the_DT mass_NN
          balance_NN constraints_NNS and_CC this_DT approach_NN is_VBZ known_VBN as_IN flux_NN
          balance_NN analysis_NN (_( FBA_NNP )_) [_NN 13_CD ,_, 14_CD ,_, 16_CD ]_NN (_( see_VB the_DT
          supplementary_JJ information_NN for_IN an_DT FBA_NNP primer_NN )_) ._. The_DT mass_NN
          balance_NN constraints_NNS in_IN a_DT metabolic_JJ network_NN can_MD be_VB
          represented_VBN mathematically_RB by_IN a_DT matrix_NN equation_NN :_:
          S_NNP •_NN v_NN =_SYM 0_CD Equation_NNP 1_CD
          The_DT matrix_NN 
          S_NNP is_VBZ the_DT 
          mxn_NN stoichiometric_JJ matrix_NN ,_, where_WRB 
          m_NN is_VBZ the_DT number_NN of_IN metabolites_NNS and_CC 
          n_NN is_VBZ the_DT number_NN of_IN reactions_NNS in_IN the_DT
          network_NN (_( The_DT 
          E_NNP ._. coli_NNS stoichiometric_JJ matrix_NN is_VBZ
          available_JJ in_IN matrix_NN format_NN in_IN the_DT supplementary_JJ
          information_NN and_CC in_IN a_DT reaction_NN list_NN in_IN Appendices_NNP 1_CD -_: 3_LS )_) ._.
          The_DT vector_NN 
          v_NN represents_VBZ all_DT fluxes_NNS in_IN the_DT
          metabolic_JJ network_NN ,_, including_VBG the_DT internal_JJ fluxes_NNS ,_,
          transport_NN fluxes_NNS and_CC the_DT growth_NN flux_NN ._.
          For_IN the_DT 
          E_NNP ._. coli_NNS metabolic_JJ network_NN
          represented_VBN by_IN Eqn_NNP ._. 1_LS ,_, the_DT number_NN of_IN fluxes_NNS was_VBD greater_JJR
          than_IN the_DT number_NN of_IN mass_NN balance_NN constraints_NNS ;_: thus_RB ,_, there_EX
          were_VBD multiple_JJ feasible_JJ flux_NN distributions_NNS that_WDT satisfied_VBD
          the_DT mass_NN balance_NN constraints_NNS ,_, and_CC the_DT solutions_NNS (_( or_CC
          feasible_JJ metabolic_JJ flux_NN distributions_NNS )_) were_VBD confined_VBN to_TO
          the_DT nullspace_NN of_IN the_DT matrix_NN 
          S_NNP ._.
          In_IN addition_NN to_TO the_DT mass_NN balance_NN constraints_NNS ,_, we_PRP
          imposed_VBD constraints_NNS on_IN the_DT magnitude_NN of_IN individual_JJ
          metabolic_JJ fluxes_NNS ._.
          α_NN 
          
            i_NNP 
           ≤_NN v_NN 
          
            i_NNP 
           ≤_NN β_NN 
          
            i_NNP 
           Equation_NNP 2_CD
          The_DT linear_JJ inequality_NN constraints_NNS were_VBD used_VBN to_TO enforce_VB
          the_DT reversibility_NN of_IN each_DT metabolic_JJ reaction_NN and_CC the_DT
          maximal_NN flux_NN in_IN the_DT transport_NN reactions_NNS ._. The_DT
          reversibility_NN constraints_NNS for_IN each_DT reaction_NN are_VBP indicated_VBN
          online_NN ._. The_DT transport_NN flux_NN for_IN inorganic_JJ phosphate_NN ,_,
          ammonia_NN ,_, carbon_NN dioxide_NN ,_, sulfate_NN ,_, potassium_NN ,_, and_CC sodium_NN
          was_VBD unrestrained_JJ (_( α_NN 
          
            i_NNP 
           =_SYM -_: ∞_NN and_CC β_NN 
          
            i_NNP 
           =_SYM ∞_NN )_) ._. The_DT transport_NN flux_NN for_IN the_DT other_JJ metabolites_NNS ,_,
          when_WRB available_JJ in_IN the_DT 
          in_IN silico_NN medium_NN ,_, was_VBD constrained_VBN
          between_IN zero_CD and_CC the_DT maximal_NN level_NN (_( 0_CD ≤_NN v_NN 
          
            i_NNP 
           ≤_NN v_NN 
          
            i_NNP 
           max_NN )_) ._. The_DT v_NN 
          
            i_NNP 
           
          max_NN values_NNS used_VBN in_IN the_DT simulations_NNS
          are_VBP noted_VBN for_IN each_DT simulation_NN (_( Fig_NNP ._. 1_LS )_) ._. When_WRB a_DT metabolite_NN
          was_VBD not_RB available_JJ in_IN the_DT medium_NN ,_, the_DT transport_NN flux_NN was_VBD
          constrained_VBN to_TO zero_CD ._. The_DT transport_NN flux_NN for_IN metabolites_NNS
          capable_JJ of_IN leaving_VBG the_DT metabolic_JJ network_NN (_( i_NNP ._. e_SYM ._. acetate_NN ,_,
          ethanol_NN ,_, lactate_NN ,_, succinate_NN ,_, formate_NN ,_, and_CC pyruvate_NN )_) was_VBD
          always_RB unconstrained_JJ in_IN the_DT net_NN outward_RB direction_NN ._.
          The_DT intersection_NN of_IN the_DT nullspace_NN and_CC the_DT region_NN
          defined_VBN by_IN the_DT linear_JJ inequalities_NNS defined_VBD a_DT region_NN in_IN
          flux_NN space_NN that_IN we_PRP will_MD refer_VB to_TO as_IN the_DT feasible_JJ set_VBN ,_, and_CC
          the_DT feasible_JJ set_VBN defined_VBD the_DT capabilities_NNS of_IN the_DT
          metabolic_JJ network_NN subject_JJ to_TO the_DT imposed_VBN cellular_JJ
          constraints_NNS ._. It_PRP should_MD be_VB noted_VBN that_IN every_DT vector_NN 
          v_NN within_IN the_DT feasible_JJ set_VBN is_VBZ not_RB
          reachable_JJ by_IN the_DT cell_NN under_IN a_DT given_VBN condition_NN due_JJ to_TO
          other_JJ constraints_NNS not_RB considered_VBN in_IN the_DT analysis_NN (_( i_NNP ._. e_SYM ._.
          maximal_NN internal_JJ fluxes_NNS and_CC gene_NN regulation_NN )_) ._. The_DT
          feasible_JJ set_VBN can_MD be_VB further_RBR reduced_VBN by_IN imposing_VBG
          additional_JJ constraints_NNS (_( i_NNP ._. e_SYM ._. kinetic_JJ or_CC gene_NN regulatory_JJ
          constraints_NNS )_) ,_, and_CC in_IN the_DT limiting_VBG condition_NN where_WRB all_DT
          constraints_NNS are_VBP known_VBN ,_, the_DT feasible_JJ set_VBN may_MD reduce_VB to_TO a_DT
          single_JJ point_NN ._.
          A_DT particular_JJ metabolic_JJ flux_NN distribution_NN within_IN the_DT
          feasible_JJ set_VBN (_( vector_NN 
          v_NN which_WDT satisfies_VBZ the_DT constraints_NNS in_IN
          Eqns_NNP ._. 1_LS and_CC 2_LS )_) was_VBD found_VBN using_VBG linear_JJ programming_NN (_( LP_NNP )_) ._. A_DT
          commercially_RB available_JJ LP_NNP package_NN was_VBD used_VBN (_( LINDO_NNP ,_, Lindo_NNP
          Systems_NNPS Inc_NNP ._. ,_, Chicago_NNP ,_, II_NNP )_) ._. LP_NNP identified_VBD a_DT solution_NN that_WDT
          minimized_VBN a_DT metabolic_JJ objective_NN function_NN (_( subject_JJ to_TO the_DT
          imposed_VBN constraints-_NN Eqns_NNP ._. 1_LS and_CC 2_LS )_) [_NN 16_CD ,_, 48_CD ,_, 49_CD ]_NN ,_, and_CC
          was_VBD formulated_VBN as_IN shown_VBN below_IN :_:
          Minimize_NNP -_: Z_NNP
          where_WRB 
          Z_NNP =_SYM Σ_NN 
          c_SYM 
          
            i_NNP 
           v_NN 
          
            i_NNP 
           =_SYM <_NN c_SYM •_NN v_NN >_NN Equation_NNP 3_CD
          The_DT vector_NN 
          c_SYM was_VBD used_VBN to_TO select_VB a_DT linear_JJ
          combination_NN of_IN metabolic_JJ fluxes_NNS to_TO include_VB in_IN the_DT
          objective_NN function_NN [_NN 50_CD ]_NN ._. Herein_NNP ,_, 
          c_SYM was_VBD defined_VBN as_IN the_DT unit_NN vector_NN in_IN
          the_DT direction_NN of_IN the_DT growth_NN flux_NN ,_, and_CC the_DT growth_NN flux_NN was_VBD
          defined_VBN in_IN terms_NNS of_IN the_DT biosynthetic_JJ requirements_NNS :_:
          (_( Equation_NNP 4_LS )_)
          where_WRB 
          d_SYM 
          
            m_NN 
           is_VBZ the_DT biomass_NNS composition_NN of_IN metabolite_NN X_NNP 
          
            m_NN 
           (_( we_PRP used_VBD a_DT constant_JJ biomass_NNS composition_NN defined_VBN from_IN
          the_DT literature_NN [_NN 51_CD ]_NN (_( see_VB Appendix_NNP 4_LS )_) )_) ,_, and_CC the_DT growth_NN
          flux_NN was_VBD modeled_VBN as_IN a_DT single_JJ reaction_NN that_WDT converts_VBZ all_PDT
          the_DT biosynthetic_JJ precursors_NNS into_IN biomass_NNS ._.
        
        
          Phenotype_NNP Phase_NN Plane_NNP Analysis_NNP
          All_DT feasible_JJ 
          E_NNP ._. coli_NNS in_IN silico_NN metabolic_JJ flux_NN
          distributions_NNS are_VBP mathematically_RB confined_VBN to_TO the_DT feasible_JJ
          set_VBN ,_, which_WDT is_VBZ a_DT region_NN in_IN flux_NN space_NN (_( n_NN )_) ,_, where_WRB each_DT
          solution_NN in_IN this_DT space_NN corresponds_NNS to_TO a_DT feasible_JJ
          metabolic_JJ flux_NN distribution_NN ._.
          Phenotype_NNP Phase_NN Plane_NNP (_( PhPP_NNP )_) :_: A_DT PhPP_NNP is_VBZ a_DT
          two-dimensional_JJ projection_NN of_IN the_DT feasible_JJ set_VBN ,_, and_CC below_IN
          we_PRP will_MD briefly_NN discuss_VBP the_DT formalism_NN for_IN constructing_VBG
          the_DT PhPP_NNP ._. Two_CD parameters_NNS that_WDT describe_VBP the_DT growth_NN
          conditions_NNS (_( such_JJ as_IN substrate_NN and_CC oxygen_NN uptake_NN rates_NNS )_)
          were_VBD defined_VBN as_IN the_DT two_CD axes_NNS of_IN the_DT two_CD dimensional_NN
          space_NN ._. The_DT optimal_NN flux_NN distribution_NN was_VBD calculated_VBN
          (_( using_VBG LP_NNP )_) for_IN all_DT points_NNS in_IN this_DT plane_NN by_IN solving_VBG the_DT LP_NNP
          problem_NN while_IN adjusting_VBG the_DT exchange_NN flux_NN constraints_NNS
          (_( defining_VBG the_DT two-dimensional_JJ space_NN )_) ._. A_DT finite_JJ number_NN of_IN
          qualitatively_RB different_JJ patterns_NNS of_IN metabolic_JJ pathway_NN
          utilization_NN were_VBD identified_VBN in_IN such_JJ a_DT plane_NN ,_, and_CC lines_NNS
          were_VBD drawn_VBN to_TO demarcate_NN these_DT regions_NNS ._. Each_DT region_NN is_VBZ
          denoted_JJ by_IN Pn_NNP 
          x_SYM ,_, y_NN ,_, where_WRB '_POS P_NN '_'' indicates_VBZ that_IN the_DT
          region_NN was_VBD defined_VBN by_IN a_DT phenotype_NN phase_NN plane_NN analysis_NN ,_,
          'n'_CC denotes_NNS the_DT number_NN of_IN the_DT demarcated_JJ phase_NN (_( as_IN shown_VBN
          in_IN a_DT particular_JJ PhPP_NNP figure_NN )_) ,_, and_CC '_POS x_SYM ,_, y_NN '_'' denotes_NNS the_DT two_CD
          uptake_NN rates_NNS on_IN the_DT axis_NNS of_IN the_DT PhPP_NNP ._. PhPPs_NNP were_VBD also_RB
          generated_VBN for_IN mutant_JJ genotypes_NNS ;_: represented_VBD as_IN P_NN genen_NN 
          x_SYM ,_, y_NN ._.
          One_CD demarcation_NN line_NN in_IN the_DT PhPP_NNP was_VBD defined_VBN as_IN the_DT
          line_NN of_IN optimality_NN (_( LO_NNP )_) ._. The_DT LO_NNP represents_VBZ the_DT optimal_NN
          relation_NN between_IN exchange_NN fluxes_NNS defined_VBN on_IN the_DT axes_NNS of_IN
          the_DT PhPP_NNP ._.
        
        
          Alterations_NNP of_IN the_DT genotype_NN
          FBA_NNP and_CC 
          E_NNP ._. coli_NNS in_IN silico_NN were_VBD used_VBN to_TO
          examine_VB the_DT systemic_JJ effects_NNS of_IN in_IN 
          silico_NN gene_NN deletions_NNS ._. The_DT genes_NNS
          involved_VBN in_IN the_DT central_JJ metabolic_JJ pathways_NNS (_( glycolysis_NNS ,_,
          pentose_NN phosphate_NN pathway_NN ,_, TCA_NNP cycle_NN ,_, electron_NN transport_NN )_)
          were_VBD subjected_VBN to_TO removal_NN from_IN 
          E_NNP ._. coli_NNS in_IN silico_NN ._. To_TO simulate_VBP a_DT
          gene_NN deletion_NN ,_, all_DT metabolic_JJ reactions_NNS catalyzed_JJ by_IN a_DT
          given_VBN gene_NN product_NN were_VBD simultaneously_RB constrained_VBN to_TO
          zero_CD ._. Some_DT metabolic_JJ reactions_NNS were_VBD catalyzed_JJ by_IN more_JJR
          than_IN one_CD enzyme_NN ,_, and_CC all_DT genes_NNS that_WDT code_NN for_IN enzymes_NNS that_WDT
          catalyze_NN a_DT given_VBN reaction_NN were_VBD simultaneously_RB removed_VBN
          (_( i_NNP ._. e_SYM ._. 
          rpiAB_NN )_) ._. Furthermore_RB ,_, all_DT genes_NNS
          that_WDT make_VBP up_RP an_DT enzyme_NN complex_NN were_VBD also_RB simultaneously_RB
          removed_VBN (_( i_NNP ._. e_SYM ._. 
          sdhABCD_NN )_) ._.
          The_DT optimal_NN metabolic_JJ flux_NN distribution_NN for_IN the_DT
          generation_NN of_IN biomass_NNS was_VBD calculated_VBN for_IN each_DT 
          in_IN silico_NN deletion_NN strain_NN ._. The_DT 
          in_IN silico_NN gene_NN deletion_NN analysis_NN
          was_VBD performed_VBN with_IN the_DT transport_NN flux_NN constraints_NNS defined_VBN
          by_IN the_DT wild-type_JJ PhPP_NNP ._. The_DT constraints_NNS imposed_VBN for_IN each_DT
          simulation_NN are_VBP noted_VBN in_IN Fig_NNP ._. 1_LS ._.
          For_IN each_DT 
          in_IN silico_NN deletion_NN strain_NN ,_, the_DT
          optimal_NN production_NN of_IN the_DT twelve_CD biosynthetic_JJ precursors_NNS
          and_CC the_DT metabolic_JJ cofactors_NNS was_VBD also_RB calculated_VBN to_TO
          identify_VB auxotrophic_JJ requirements_NNS and_CC impaired_VBN functions_NNS
          in_IN the_DT metabolic_JJ network_NN (_( Table_NNP 1_LS )_) ._. The_DT optimal_NN
          production_NN of_IN the_DT biosynthetic_JJ precursors_NNS was_VBD calculated_VBN
          by_IN setting_VBG the_DT objective_NN function_NN to_TO the_DT drain_NN of_IN a_DT
          single_JJ metabolite_NN (_( i_NNP ._. e_SYM ._. ,_, ATP_NNP →_NN ADP_NNP +_NN P_NN 
          i_NNP ,_, or_CC PEP_NNP →_NN )_) ._. The_DT numerical_JJ value_NN of_IN
          the_DT objective_NN function_NN for_IN each_DT 
          in_IN silico_NN deletion_NN strain_NN was_VBD
          reported_VBN as_IN a_DT fraction_NN of_IN the_DT wild-type_JJ optimal_NN value_NN
          (_( Table_NNP 1_LS )_) ._.
        
      
      
        Results_NNS
        We_PRP have_VBP previously_RB described_VBN the_DT construction_NN of_IN
        phenotype_NN phase_NN planes_NNS (_( PhPPs_NNP )_) (_( see_VB materials_NNS and_CC methods_NNS )_)
        and_CC the_DT analysis_NN of_IN the_DT glucose-oxygen_JJ PhPP_NNP ._. We_PRP have_VBP
        previously_RB described_VBN the_DT effect_NN of_IN 
        in_IN silico_NN '_'' gene_NN deletions_NNS '_POS on_IN the_DT
        ability_NN of_IN 
        E_NNP ._. coli_NNS in_IN silico_NN to_TO '_POS grow_VB '_POS under_IN a_DT
        single_JJ condition_NN [_NN 18_CD ]_NN ._. Since_IN the_DT utilization_NN of_IN the_DT
        metabolic_JJ pathways_NNS is_VBZ condition_NN dependent_JJ ,_, herein_NN ,_, we_PRP have_VBP
        investigated_VBN the_DT link_NN between_IN the_DT environmental_JJ conditions_NNS
        and_CC the_DT optimal_NN metabolic_JJ pathway_NN utilization_NN 
        in_IN silico_NN by_IN :_: 1_CD ._. studying_VBG the_DT effects_NNS
        of_IN gene_NN deletions_NNS in_IN all_DT phases_NNS of_IN the_DT glucose-oxygen_JJ PhPP_NNP ,_,
        and_CC 2_CD ._. broadening_VBG the_DT analysis_NN of_IN 
        in_IN silico_NN deletion_NN strains_NNS by_IN
        comparing_VBG PhPPs_NNP from_IN isogenic_JJ 
        in_IN silico_NN strains_NNS ._.
        
        Gene_NNP Deletions_NNP :_: A_DT point_NN within_IN each_DT
        phase_NN of_IN the_DT glucose-oxygen_JJ PhPP_NNP was_VBD chosen_VBN to_TO define_VB the_DT
        transport_NN flux_NN constraints_NNS (_( indicated_VBD in_IN Fig_NNP ._. 1_LS )_) for_IN the_DT
        FBA_NNP simulations_NNS ._. At_IN each_DT point_NN ,_, the_DT growth_NN characteristics_NNS
        of_IN all_DT 
        in_IN silico_NN gene_NN deletion_NN strains_NNS (_( of_IN
        central_JJ metabolic_JJ pathway_NN genes_NNS )_) were_VBD examined_VBN ._. Based_VBN on_IN
        the_DT results_NNS ,_, the_DT genes_NNS were_VBD categorized_VBN as_IN ;_: 
        essential_JJ (_( growth_NN under_IN the_DT defined_VBN
        condition_NN requires_VBZ the_DT activity_NN of_IN the_DT corresponding_JJ gene_NN
        product_NN )_) ,_, 
        critical_JJ (_( growth_NN at_IN a_DT reduced_VBN yield_NN
        (_( <_NN 95_CD %_NN of_IN wild-type_JJ )_) )_) ,_, or_CC 
        non-essential_JJ (_( growth_NN at_IN near_IN
        wild-type_JJ yield_NN (_( >_NN 95_CD %_NN )_) )_) ._. The_DT effects_NNS of_IN the_DT 
        in_IN silico_NN gene_NN deletions_NNS were_VBD
        phase-dependent_JJ ,_, allowing_VBG us_PRP to_TO identify_VB optimal_NN growth_NN
        phenotypes_NNS for_IN each_DT growth_NN condition_NN ._. Additionally_RB ,_, the_DT
        optimal_NN production_NN of_IN the_DT 12_CD biosynthetic_JJ precursors_NNS ,_,
        high-energy_JJ phosphate_NN bonds_NNS ,_, and_CC redox_NN potential_NN was_VBD
        calculated_VBN for_IN each_DT 
        in_IN silico_NN deletion_NN strain_NN (_( Table_NNP 1_LS )_)
        to_TO determine_VB the_DT specific_JJ effect_NN of_IN the_DT gene_NN deletion_NN on_IN
        the_DT metabolic_JJ capabilities_NNS ._. For_IN instance_NN ,_, the_DT 
        in_IN silico_NN acnAB_NN '_'' strain_NN was_VBD unable_JJ to_TO
        synthesize_VB α-ketoglutarate_JJ under_IN all_DT simulated_JJ growth_NN
        conditions_NNS ,_, and_CC thus_RB ,_, 
        acnAB_NN was_VBD defined_VBN as_IN essential_JJ for_IN
        growth_NN in_IN a_DT glucose_NN minimal_JJ media_NNS (_( Table_NNP 1_LS )_) ._.
        The_DT optimal_NN utilization_NN of_IN the_DT metabolic_JJ pathways_NNS was_VBD
        dependent_JJ on_IN the_DT specific_JJ transport_NN flux_NN constraints_NNS ,_, and_CC
        the_DT qualitative_JJ shifts_NNS in_IN optimal_NN metabolic_JJ behavior_NN as_IN a_DT
        function_NN of_IN two_CD transport_NN fluxes_NNS are_VBP shown_VBN in_IN the_DT PhPP_NNP ._. The_DT
        optimal_NN biomass_NNS yield_VBP and_CC biosynthetic_JJ precursor_NN production_NN
        capabilities_NNS were_VBD calculated_VBN for_IN each_DT 
        E_NNP ._. coli_NNS in_IN silico_NN deletion_NN strain_NN for_IN
        a_DT point_NN within_IN each_DT region_NN of_IN the_DT PhPP_NNP ,_, and_CC the_DT optimal_NN
        values_NNS were_VBD normalized_JJ to_TO the_DT wild-type_JJ (_( Fig_NNP ._. 1_LS )_) ._. The_DT
        condition_NN dependent_JJ metabolic_JJ phenotypes_NNS were_VBD
        computationally_RB analyzed_VBN ,_, and_CC the_DT results_NNS are_VBP organized_VBN by_IN
        the_DT overall_JJ metabolic_JJ phenotype_NN ;_: 
        essential_JJ ,_, conditionally_RB
        essential_JJ ,_, or_CC 
        non-essential_JJ genes_NNS ._. 
        
        Essential_NNP genes_NNS :_: The_DT gene_NN products_NNS
        that_WDT were_VBD essential_JJ for_IN growth_NN with_IN conditions_NNS defined_VBN by_IN
        the_DT line_NN of_IN optimality_NN (_( LO_NNP )_) (_( see_VB materials_NNS and_CC methods_NNS )_)
        were_VBD also_RB identified_VBN as_IN essential_JJ within_IN all_DT other_JJ phases_NNS (_(
        
        acnAB_NN ,_, gapAC_NN ,_, gltA_NN ,_, icdA_NN ,_, pgk_NN ,_, rpiAB_NN ,_,
        tktAB_NN )_) ._. Specifically_RB ,_, the_DT 
        gltA_NN -_: ,_, 
        icdA_NN -_: ,_, and_CC 
        acnAB_NN -_: 
        in_IN silico_NN deletion_NN strains_NNS were_VBD
        unable_JJ to_TO produce_VB one_CD biosynthetic_JJ precursor_NN
        (_( α-ketoglutarate_JJ ,_, Table_NNP 1_LS )_) ,_, and_CC retained_VBD the_DT capability_NN to_TO
        synthesize_VB the_DT remaining_VBG biosynthetic_JJ precursors_NNS and_CC
        cofactors_NNS nearly_RB equivalent_JJ to_TO the_DT wild-type_JJ ._. This_DT
        prediction_NN is_VBZ consistent_JJ with_IN the_DT defined_VBN media_NNS required_VBN
        for_IN the_DT cultivation_NN of_IN 
        aglt_NN -_: 
        E_NNP ._. coli_NNS mutant_JJ strain_NN (_( glucose_NN
        minimal_JJ media_NNS supplemented_JJ with_IN glutamine_NN or_CC proline_NN )_) [_NN
        26_CD ]_NN ._. Furthermore_RB ,_, the_DT essential_JJ glycolytic_JJ gene_NN products_NNS (_( 
        pgk_NN ,_, gapAC_NN )_) were_VBD required_VBN for_IN the_DT
        synthesis_NN of_IN oxaloacetate_NN ,_, succinyl-_NN CoA_NNP ,_, α-ketoglutarate_JJ ,_,
        pyruvate_NN ,_, phosphoenolpyruvate_NN (_( PEP_NNP )_) ,_, and_CC 3_CD -_: phosphoglycerate_NN
        within_IN all_DT conditions_NNS ,_, and_CC were_VBD unable_JJ to_TO synthesize_VB all_DT
        biosynthetic_JJ precursors_NNS under_IN anaerobic_JJ growth_NN conditions_NNS ._.
        The_DT remaining_VBG two_CD essential_JJ gene_NN products_NNS were_VBD in_IN the_DT
        pentosephosphate_NN pathway_NN (_( 
        tktAB_NN ,_, rpiAB_NN )_) ._. The_DT 
        tktAB_NN and_CC 
        rpiAB_NN gene_NN products_NNS were_VBD required_VBN for_IN
        the_DT synthesis_NN of_IN erythrose_NN 4_CD -_: phosphate_NN in_IN all_DT phases_NNS
        (_( aromatic_JJ amino_JJ acid_NN supplement_NN required_VBN for_IN the_DT
        cultivation_NN of_IN 
        tkt_NN -_: 
        E_NNP ._. coli_NNS mutant_JJ strains_NNS [_NN 27_CD ]_NN )_) ._.
        Additionally_RB ,_, 
        rpiAB_NN -_: strains_NNS were_VBD identified_VBN as_IN
        ribose_NN auxotrophs_NNS by_IN the_DT 
        in_IN silico_NN analysis_NN ,_, which_WDT was_VBD
        consistent_JJ with_IN experimental_JJ data_NNS [_NN 28_CD ]_NN ._.
        
        Conditionally_NNP essential_JJ genes_NNS :_:
        During_IN the_DT growth_NN simulations_NNS with_IN external_JJ parameters_NNS
        defined_VBN by_IN the_DT LO_NNP ,_, there_EX were_VBD genes_NNS defined_VBN as_IN critical_JJ for_IN
        growth_NN ;_: however_RB ,_, many_JJ of_IN these_DT genes_NNS were_VBD essential_JJ for_IN
        cellular_JJ growth_NN upon_IN oxygen_NN limitations_NNS (_( 
        fba_NN ,_, pfkAB_NN ,_, tpiA_NN ,_, eno_NN ,_, gpmAB_NN )_) ._. These_DT
        genes_NNS were_VBD termed_VBN conditionally_RB essential_JJ ._. The_DT 
        fba_NN -_: ,_, 
        pfkAB_NN -_: ,_, and_CC 
        tpiA_NN -_: 
        in_IN silico_NN deletion_NN strains_NNS had_VBD a_DT
        limited_JJ capability_NN to_TO synthesize_VB glyceraldehyde_NN
        3_CD -_: phosphate_NN ,_, 3_CD -_: phosphoglycerate_NN ,_, phosphoenolpyruvate_NN ,_,
        pyruvate_NN ,_, acetyl-_NN CoA_NNP ,_, α-ketoglutarate_JJ ,_, succinyl-_NN CoA_NNP ,_,
        oxaloacetate_NN ,_, and_CC high-energy_JJ phosphate_NN bonds_NNS in_IN all_DT
        phases_NNS ,_, and_CC were_VBD completely_RB unable_JJ to_TO synthesize_VB many_JJ of_IN
        the_DT biosynthetic_JJ precursors_NNS in_IN phases_NNS 46_CD (_( Table_NNP 1_LS )_) (_( 
        tpi_NN -_: 
        in_IN silico_NN strain_NN discussed_VBN below_IN )_) ._.
        The_DT growth_NN potential_NN of_IN the_DT 
        eno_NN -_: and_CC 
        gpmAB_NN -_: 
        in_IN silico_NN deletion_NN strains_NNS was_VBD
        theoretically_RB maintained_VBN under_IN aerobic_JJ conditions_NNS by_IN the_DT
        synthesis_NN and_CC degradation_NN of_IN serine_NN ,_, and_CC without_IN the_DT serine_NN
        degradation_NN pathway_NN ,_, the_DT 
        eno_NN -_: and_CC 
        gpmAB_NN -_: gene_NN products_NNS were_VBD defined_VBN as_IN
        essential_JJ ._. However_RB ,_, the_DT 
        eno_NN -_: and_CC 
        gpmAB_NN -_: 
        in_IN silico_NN deletion_NN strains_NNS were_VBD
        limited_VBN in_IN their_PRP$ production_NN capability_NN of_IN high-energy_JJ
        phosphate_NN bonds_NNS under_IN all_DT conditions_NNS ,_, and_CC were_VBD unable_JJ to_TO
        produce_VB any_DT of_IN the_DT biosynthetic_JJ precursors_NNS in_IN phase_NN 6_CD even_RB
        with_IN the_DT serine_NN degradation_NN pathway_NN ._.
        Additionally_RB ,_, several_JJ LO_NNP non-essential_JJ gene_NN products_NNS
        were_VBD essential_JJ (_( 
        sdhABCD_NN ,_, ppc_NN ,_, frdABCD_NN )_) for_IN growth_NN
        within_IN other_JJ phases_NNS ._. The_DT 
        in_IN silico_NN analysis_NN suggested_VBD that_DT the_DT
        
        sdhABCD_NN and_CC 
        frdABCD_NN gene_NN products_NNS were_VBD required_VBN
        for_IN anaerobic_JJ pyrimidine_NN biosynthesis_NNS ._. Additionally_RB ,_, the_DT 
        frdABCD_NN gene_NN products_NNS were_VBD essential_JJ
        for_IN the_DT anaerobic_JJ synthesis_NN of_IN the_DT NAD_NNP cofactor_NN ._. However_RB ,_,
        these_DT 
        in_IN silico_NN results_NNS could_MD be_VB due_JJ to_TO
        inaccurate_JJ stoichiometric_JJ information_NN with_IN respect_NN to_TO
        cofactor_NN utilization_NN and_CC should_MD be_VB critically_RB examined_VBN ._.
        Finally_RB ,_, the_DT 
        ppc_NN gene_NN product_NN was_VBD required_VBN for_IN the_DT
        anaerobic_JJ synthesis_NN of_IN oxaloacetate_NN and_CC α-ketoglutarate_JJ ,_,
        but_CC the_DT 
        in_IN silico_NN analysis_NN suggests_VBZ that_IN this_DT
        gene_NN product_NN is_VBZ not_RB essential_JJ for_IN growth_NN in_IN aerobic_JJ
        conditions_NNS where_WRB the_DT glyoxylate_NN by-pass_JJ has_VBZ the_DT potential_NN
        to_TO replenish_VB the_DT biosynthetic_JJ precursors_NNS [_NN 29_CD ]_NN ._.
        
        Non-essential_NNP genes_NNS :_: Several_JJ genes_NNS
        that_WDT are_VBP critical_JJ for_IN growth_NN in_IN conditions_NNS defined_VBN by_IN the_DT
        LO_NNP were_VBD non-essential_JJ for_IN growth_NN in_IN other_JJ phases_NNS (_( 
        nuo_NN ,_, 
        cyoABCD_NN ,_, fumABC_NN )_) ._. The_DT 
        in_IN silico_NN nuo_NN -_: and_CC 
        cyoABCD_NN -_: deletion_NN strains_NNS were_VBD
        limited_VBN in_IN their_PRP$ production_NN capabilities_NNS of_IN high-energy_JJ
        phosphate_NN bonds_NNS for_IN aerobic_JJ growth_NN ;_: however_RB ,_, under_IN
        anaerobic_JJ conditions_NNS high-energy_JJ phosphate_NN bonds_NNS were_VBD
        produced_VBN by_IN substrate_NN level_NN phosphorylation_NN ._. The_DT production_NN
        capabilities_NNS of_IN the_DT 
        fumABC_NN -_: 
        in_IN silico_NN deletion_NN strain_NN was_VBD not_RB
        limited_VBN with_IN respect_NN to_TO the_DT biosynthetic_JJ precursors_NNS shown_VBN
        in_IN the_DT table_NN (_( other_JJ than_IN a_DT slight_JJ limitation_NN of_IN ATP_NNP
        production_NN in_IN P_NN 1_CD 
        glucose_NN ,_, oxygen_NN )_) ._. However_RB ,_, the_DT 
        fumABC_NN -_: 
        in_IN silico_NN deletion_NN strain_NN was_VBD limited_VBN
        in_IN its_PRP$ production_NN capabilities_NNS of_IN several_JJ amino_JJ acids_NNS (_( arg_NN ,_,
        gly_RB ,_, his-_NN not_RB shown_VBN in_IN table_NN )_) ,_, but_CC under_IN anaerobic_JJ
        conditions_NNS ,_, these_DT capabilities_NNS were_VBD not_RB limited_VBN with_IN
        respect_NN to_TO the_DT wild-type_JJ ._.
        Several_JJ LO_NNP non-essential_JJ gene_NN products_NNS were_VBD critical_JJ (_( 
        pgi_NN ,_, pta_NN ,_, ackAB_NN )_) for_IN growth_NN within_IN
        other_JJ phases_NNS ._. The_DT 
        in_IN silico_NN pgi_NN deletion_NN strain_NN had_VBD a_DT
        reduced_VBN capacity_NN to_TO produce_VB all_DT the_DT biosynthetic_JJ precursors_NNS
        under_IN oxygen_NN limitation_NN ,_, and_CC this_DT resulted_VBD in_IN a_DT decreased_VBN
        normalized_JJ growth_NN yield_NN of_IN this_DT 
        in_IN silico_NN deletion_NN strain_NN ._. The_DT 
        pta_NN and_CC 
        ackAB_NN gene_NN products_NNS participate_VBP in_IN
        the_DT metabolic_JJ pathway_NN leading_VBG to_TO the_DT formation_NN of_IN acetate_NN ._.
        Acetate_NNP was_VBD predicted_VBN as_IN a_DT metabolic_JJ by-product_JJ upon_IN oxygen_NN
        limitations_NNS (_( all_DT phases_NNS below_IN the_DT LO_NNP )_) ._. Under_IN conditions_NNS
        defined_VBN by_IN P_NN 5_CD -_: 6_CD 
        glucose_NN ,_, oxygen_NN ,_, the_DT production_NN
        capabilities_NNS of_IN several_JJ of_IN the_DT biosynthetic_JJ precursors_NNS
        (_( glucose_NN 6_CD -_: phosphate_NN ,_, fructose_NN 6_CD -_: phosphate_NN ,_, ribose_NN
        5_CD -_: phosphate_NN ,_, erythrose_NN 5_CD -_: phosphate_NN ,_, glyceraldehyde_NN
        3_CD -_: phosphate_NN )_) were_VBD limited_JJ in_IN the_DT 
        pta_NN and_CC 
        ackAB_NN in_IN silico_NN deletion_NN strains_NNS (_( 
        pta_NN -_: 
        In_IN silico_NN deletion_NN strain_NN discussed_VBN
        below_IN )_) ._.
        This_DT sub-section_JJ illustrated_VBD the_DT condition-dependent_JJ
        effect_NN of_IN gene_NN deletions_NNS on_IN the_DT metabolic_JJ
        genotype-phenotype_JJ relation_NN ._. The_DT results_NNS covered_VBD the_DT range_NN
        of_IN substrate_NN uptake_NN rates_NNS and_CC defined_VBD the_DT optimal_NN metabolic_JJ
        pathway_NN utilization_NN of_IN isogenic_JJ strains_NNS 
        in_IN silico_NN under_IN different_JJ
        combinations_NNS of_IN environmental_JJ parameters_NNS ._. The_DT optimal_NN
        utilization_NN of_IN the_DT metabolic_JJ pathways_NNS was_VBD dependent_JJ on_IN the_DT
        metabolic_JJ genotype_NN ;_: thus_RB ,_, different_JJ metabolic_JJ genotypes_NNS are_VBP
        characterized_VBN by_IN different_JJ PhPPs_NNP ._. The_DT results_NNS presented_VBN
        above_IN provide_VB insight_NN into_IN the_DT genotype_NN phenotype_NN relation_NN ._.
        Next_JJ ,_, we_PRP will_MD compare_VB the_DT PhPPs_NNP from_IN 
        in_IN silico_NN deletion_NN strains_NNS to_TO the_DT
        wild-type_JJ to_TO provide_VB a_DT more_RBR complete_JJ definition_NN of_IN optimal_NN
        phenotypes_NNS ._.
        
        in_IN silico_NN Deletion_NNP Strain_NNP Phenotype_NNP Phase_NN
        Plane_NNP Analysis_NNP :_: Comparative_NNP analysis_NN of_IN the_DT phase_NN
        planes_NNS for_IN several_JJ mutant_JJ strains_NNS (_( 
        tpi_NN -_: 
        ,_, pta_NN -_: 
        ,_, and_CC 
        zwf_NN )_) were_VBD performed_VBN ._. These_DT case_NN
        studies_NNS were_VBD chosen_VBN to_TO further_VB investigate_VB the_DT metabolic_JJ
        genotype-phenotype_JJ relation_NN 
        in_IN silico_NN and_CC to_TO demonstrate_VB the_DT use_NN
        of_IN FBA_NNP to_TO interpret_VB and_CC analyze_VB cellular_JJ metabolism_NN ._.
        
        tpi_NN :_: The_DT 
        tpi_NN -_: PhPP_NNP showed_VBD 3_CD distinct_JJ optimal_NN
        metabolic_JJ phenotypes-_NN one_CD glucose_NN limited_JJ phase_NN (_( P_NN 
        tpi_NN 2_CD 
        glucose_NN ,_, oxygen_NN )_) ,_, and_CC two_CD futile_JJ phases_NNS
        (_( Fig_NNP ._. 2_LS A_DT )_) ._. Futile_NNP phases_NNS are_VBP characterized_VBN by_IN a_DT negative_JJ
        effect_NN of_IN one_CD of_IN the_DT substrates_NNS on_IN the_DT objective_NN function_NN ._.
        One_CD of_IN the_DT futile_JJ phases_NNS was_VBD due_JJ to_TO excess_JJ oxygen_NN (_( P_NN 
        tpi_NN 1_CD 
        glucose_NN ,_, oxygen_NN )_) and_CC the_DT other_JJ was_VBD due_JJ
        to_TO excess_JJ glucose_NN (_( P_NN 
        tpi_NN 3_CD 
        glucose_NN ,_, oxygen_NN )_) ._. Although_IN the_DT 
        tpi_NN -_: 
        in_IN silico_NN metabolic_JJ genotype_NN
        theoretically_RB supported_VBD biomass_NNS production_NN ,_, the_DT feasible_JJ
        steady_JJ states_NNS were_VBD restricted_VBN to_TO a_DT limited_JJ phase_NN of_IN the_DT
        phase_NN plane_NN and_CC the_DT flexibility_NN of_IN the_DT metabolic_JJ network_NN
        was_VBD reduced_VBN to_TO one_CD dimension_NN ._.
        The_DT optimal_NN utilization_NN of_IN 
        the_DT tpi_NN -_: metabolic_JJ network_NN under_IN
        environmental_JJ conditions_NNS defined_VBN by_IN the_DT LO_NNP 
        tpi_NN was_VBD characterized_VBN by_IN increased_VBN
        PPP_NNP fluxes_NNS to_TO bypass_VB the_DT TPI_NNP block_NN ._. The_DT PPP_NNP operated_VBD
        cyclically_RB ;_: thus_RB ,_, leading_VBG to_TO a_DT high_JJ production_NN of_IN NADPH_NNP ._.
        Due_JJ to_TO the_DT high_JJ NADPH_NNP production_NN in_IN the_DT PPP_NNP ,_, the_DT TCA_NNP cycle_NN
        flux_NN was_VBD optimally_RB reduced_VBN and_CC functioned_VBD only_RB to_TO produce_VB
        the_DT biosynthetic_JJ precursors_NNS ._.
        The_DT 
        in_IN silico_NN analysis_NN suggests_VBZ that_IN the_DT 
        tpi_NN -_: metabolic_JJ network_NN was_VBD restricted_VBN
        by_IN the_DT ability_NN to_TO regenerate_VB phosphoenolpyruvate_NN (_( PE_NNP )_) for_IN
        the_DT PTS_NNP ,_, and_CC the_DT 
        in_IN silico_NN analysis_NN identified_VBD 3_CD
        metabolic_JJ '_POS routes_NNS '_POS for_IN the_DT regeneration_NN of_IN PEP_NNP ._. Two_CD of_IN the_NNP
        '_POS routes_NNS '_POS were_VBD equivalent_NN (_( alternate_JJ optimal_NN solutions_NNS )_) ,_, (_( 1_LS )_)
        The_DT PEP_NNP was_VBD regenerated_JJ by_IN the_DT phosphoenolpyruvate_NN synthase_NN
        (_( PPS_NNP )_) ,_, or_CC (_( 2_LS )_) the_DT glactose_NN transporter_NN was_VBD used_VBN for_IN the_DT
        transport_NN of_IN glucose_NN which_WDT was_VBD subsequently_RB phosphorylated_JJ
        by_IN the_DT glucokinase_NN reaction_NN ._. These_DT two_CD routes_NNS were_VBD
        equivalent_NN with_IN respect_NN to_TO the_DT objective_NN function_NN (_( although_IN
        they_PRP were_VBD structurally_RB different_JJ )_) ._. The_DT third_JJ PEP_NNP
        regeneration_NN route_NN involved_VBD the_DT glyoxylate_NN bypass_NN and_CC the_DT
        phosphoenolpyruvate_NN carboxykinase_NN ,_, and_CC this_DT route_NN was_VBD
        characterized_VBN by_IN a_DT 38_CD %_NN reduction_NN in_IN the_DT optimal_NN biomass_NNS
        yield_VBP ._. Furthermore_RB ,_, experimentally_RB it_PRP was_VBD shown_VBN that_IN
        constitutive_JJ expression_NN of_IN the_DT glyoxylate_NN bypass_NN suppressed_VBN
        the_DT PEP_NNP deficient_NN phenotype_NN [_NN 30_CD ,_, 31_CD ]_NN ._. The_DT PEP_NNP regeneration_NN
        routes_NNS (_( discussed_VBN above_IN )_) theoretically_RB allow_VB the_DT 
        tpi_NN -_: to_TO grow_VB ,_, and_CC one_CD of_IN these_DT
        solutions_NNS was_VBD required_VBN for_IN the_DT growth_NN of_IN the_DT 
        tpi_NN -_: 
        in_IN silico_NN strain_NN ._.
        
        zwf_NN :_: 
        zwf_NN codes_NNS for_IN glucose-_NN 6_CD -_: phosphate_NN
        dehydrogenase_NN (_( G_NNP 6_CD PDH_NNP )_) ,_, the_DT first_JJ enzyme_NN in_IN the_DT oxidative_JJ
        branch_NN of_IN the_DT PPP_NNP ._. 
        zwf_NN has_VBZ been_VBN shown_VBN to_TO be_VB a_DT
        non-essential_JJ gene_NN for_IN the_DT growth_NN of_IN 
        E_NNP ._. coli_NNS in_IN glucose_NN minimal_JJ media_NNS ,_, and_CC
        
        zwf_NN strains_NNS grow_VBP at_IN near_IN wild-type_JJ
        growth_NN rates_NNS [_NN 32_CD ]_NN ._. 
        zwf_NN was_VBD predicted_VBN by_IN FBA_NNP to_TO be_VB a_DT
        non-essential_JJ gene_NN for_IN growth_NN in_IN glucose_NN minimal_JJ media_NNS
        (_( Fig_NNP ._. 1_LS )_) ._. We_PRP conducted_VBD a_DT phenotype_NN phase_NN plane_NN analysis_NN of_IN
        the_DT 
        zwf_NN strain_NN and_CC examined_VBD the_DT systemic_JJ
        metabolic_JJ function_NN of_IN 
        zwf_NN and_CC its_PRP$ relation_NN to_TO the_DT
        environmental_JJ conditions_NNS 
        in_IN silico_NN (_( Fig_NNP ._. 2_LS B_NNP )_) ._. The_DT slope_NN of_IN the_DT
        LO_NNP 
        zwf_NN slightly_RB increased_VBD (_( relative_JJ to_TO
        the_DT wild-type_JJ )_) ,_, indicating_VBG a_DT higher_JJR oxygen_NN :_: glucose_NN ratio_NN
        for_IN optimal_NN growth_NN ._. Removing_NNP the_DT G_NNP 6_CD PDH_NNP from_IN the_DT metabolic_JJ
        network_NN eliminated_VBD all_DT metabolic_JJ pathways_NNS that_IN utilized_JJ the_DT
        oxidative_JJ branch_NN of_IN the_DT PPP_NNP ._. Therefore_RB ,_, the_DT 
        zwf_NN PhPP_NNP was_VBD significantly_RB changed_JJ in_IN
        the_DT phases_NNS that_IN utilized_JJ the_DT oxidative_JJ branch_NN of_IN the_DT PPP_NNP (_( P_NN
        
        zwf_NN 2_CD 
        glucose_NN ,_, oxygen_NN and_CC P_NN 
        zwf_NN 3_CD 
        glucose_NN ,_, oxygen_NN )_) but_CC was_VBD unchanged_JJ in_IN
        phases_NNS that_WDT did_VBD not_RB optimally_RB utilize_VB the_DT 
        zwf_NN gene_NN product_NN (_( P_NN 
        zwf_NN 4_CD 
        glucose_NN ,_, oxygen_NN )_) ._.
        
        pta_NN :_: Acetate_NNP excretion_NN is_VBZ a_DT common_JJ
        characteristic_NN of_IN 
        E_NNP ._. coli_NNS metabolism_NN and_CC several_JJ
        approaches_NNS have_VBP been_VBN applied_VBN to_TO reduce_VB acetate_NN production_NN
        to_TO improve_VB the_DT productivity_NN of_IN engineering_NN strains_NNS [_NN 33_CD ,_,
        34_CD ,_, 35_CD ]_NN ._. Acetate_NNP production_NN can_MD be_VB interpreted_VBN using_VBG FBA_NNP [_NN
        36_CD ,_, 37_CD ]_NN ,_, and_CC we_PRP have_VBP used_VBN a_DT phase_NN plane_NN analysis_NN to_TO
        quantitatively_RB analyze_VB the_DT conditions_NNS for_IN which_WDT acetate_NN
        excretion_NN optimally_RB occurs_VBZ ._. Acetate_NNP was_VBD optimally_RB excreted_JJ
        from_IN the_DT cell_NN within_IN all_DT phases_NNS of_IN the_DT glucose-oxygen_JJ PhPP_NNP
        below_IN the_DT LO_NNP ._. We_PRP have_VBP generated_VBN the_DT 
        pta_NN -_: PhPP_NNP and_CC analyzed_VBD the_DT metabolic_JJ
        characteristics_NNS of_IN the_DT in_IN 
        silico_NN pta_NN -_: strain_NN (_( Fig_NNP ._. 2_LS C_NNP )_) ._. The_DT 
        pta_NN -_: PhPP_NNP indicated_VBD that_IN this_DT mutant_JJ
        strain_NN maintained_VBD the_DT potential_NN to_TO support_VB growth_NN (_( both_DT
        aerobically_RB and_CC anaerobically_RB )_) ._. Experimentally_NNP ,_, 
        the_DT pta_NN -_: 
        E_NNP ._. coli_NNS strain_VBP has_VBZ been_VBN shown_VBN to_TO grow_VB
        aerobically_RB and_CC anaerobically_RB on_IN glucose_NN minimal_JJ media_NNS [_NN
        38_CD ]_NN ._. The_DT 
        in_IN silico_NN analysis_NN predicted_VBD that_IN 
        the_DT pta_NN -_: strain_NN optimally_RB shifted_VBD the_DT
        carbon_NN flux_NN from_IN acetate_NN to_TO ethanol_NN in_IN P_NN 
        pta_NN 3_CD ._. However_RB ,_, in_IN P_NN 
        pta_NN 4_CD ,_, the_DT optimal_NN metabolic_JJ
        by-products_JJ included_JJ lactate_NN ,_, ethanol_NN ,_, and_CC pyruvate_NN ,_, and_CC
        under_IN completely_RB anaerobic_JJ conditions_NNS ,_, succinate_NN was_VBD also_RB
        optimally_RB produced_VBN as_IN a_DT metabolic_JJ byproduct_NN ._. These_DT
        metabolic_JJ byproducts_NNS were_VBD qualitatively_RB consistent_JJ with_IN
        experimental_JJ observations_NNS in_IN the_DT 
        pta_NN -_: strain_NN [_NN 38_CD ]_NN ._.
      
      
        Discussion_NNP
        The_DT rapid_JJ development_NN of_IN bioinformatic_JJ databases_NNS is_VBZ
        resulting_VBG in_IN extensive_JJ information_NN about_IN the_DT molecular_JJ
        composition_NN and_CC function_NN of_IN several_JJ single_JJ cellular_JJ
        organisms_NNS ._. These_DT genetic_JJ and_CC biochemical_JJ databases_NNS [_NN 21_CD ,_,
        23_CD ,_, 39_CD ]_NN have_VBP now_RB been_VBN developed_VBN to_TO the_DT point_NN where_WRB the_DT
        methods_NNS of_IN systems_NNS science_NN need_VBP to_TO be_VB used_VBN to_TO analyze_VB ,_,
        interpret_VB ,_, and_CC predict_VBP the_DT integrated_VBN behavior_NN of_IN complex_JJ
        multigeneic_JJ biological_JJ processes_NNS ._. Herein_NNP ,_, we_PRP have_VBP utilized_JJ
        an_DT 
        in_IN silico_NN representation_NN of_IN 
        E_NNP ._. coli_NNS to_TO study_VB the_DT condition_NN
        dependent_JJ phenotype_NN of_IN 
        E_NNP ._. coli_NNS and_CC central_JJ metabolism_NN gene_NN
        deletion_NN strains_NNS ._. We_PRP have_VBP shown_VBN that_IN a_DT computational_NN
        analysis_NN of_IN the_DT metabolic_JJ behavior_NN can_MD provide_VB valuable_JJ
        insight_NN into_IN cellular_JJ metabolism_NN ._. The_DT results_NNS presented_VBD
        herein_NN address_VBP a_DT pressing_VBG question_NN in_IN the_DT post-genome_JJ era_NN ;_: 
        how_WRB can_MD genome_NN sequence_NN information_NN be_VB
        used_VBN to_TO analyze_VB integrated_VBN cellular_JJ functions_NNS ?_. Given_VBN
        the_DT central_JJ importance_NN of_IN this_DT question_NN ,_, we_PRP will_MD discuss_VB
        the_DT general_JJ applicability_NN ,_, limitations_NNS ,_, and_CC future_JJ
        prospects_NNS for_IN FBA_NNP and_CC functional_JJ genomics_NNS ._.
        The_DT FBA_NNP metabolic_JJ modeling_NN framework_NN is_VBZ different_JJ than_IN
        other_JJ well-known_JJ metabolic_JJ modeling_NN approaches_NNS ._. FBA_NNP can_MD
        more_RBR accurately_RB be_VB defined_VBN as_IN a_DT metabolic_JJ constraining_VBG
        approach_NN ,_, this_DT is_VBZ because_IN FBA_NNP defines_VBZ the_NNP '_POS best_JJS '_POS the_DT cell_NN
        can_MD do_VB ,_, rather_RB than_IN predicting_VBG the_DT metabolic_JJ behavior_NN ._. To_TO
        accomplish_VB this_DT ,_, we_PRP have_VBP constrained_VBN metabolic_JJ function_NN
        based_VBN on_IN the_DT most_RBS reliable_JJ information_NN ,_, the_DT metabolic_JJ
        stoichiometry_NN (_( the_DT stoichiometry_NN is_VBZ well_RB known_VBN for_IN the_DT vast_JJ
        majority_NN of_IN the_DT metabolic_JJ processes_VBZ )_) ._. However_RB ,_, FBA_NNP does_VBZ
        have_VB predictive_JJ capabilities_NNS when_WRB a_DT physiologically_RB
        meaningful_JJ objective_NN function_NN can_MD be_VB defined_VBN ,_, and_CC the_DT 
        E_NNP ._. coli_NNS FBA_NNP results_NNS ,_, with_IN maximal_NN
        growth_NN rate_NN as_IN the_DT objective_NN function_NN ,_, have_VBP been_VBN shown_VBN to_TO
        be_VB consistent_JJ with_IN experimental_JJ data_NNS under_IN nutritionally_RB
        rich_JJ conditions_NNS [_NN 40_CD ]_NN ._. It_PRP should_MD be_VB mentioned_VBN that_IN FBA_NNP does_VBZ
        not_RB directly_RB consider_VB regulation_NN ,_, or_CC the_DT regulatory_JJ
        constraints_NNS on_IN the_DT metabolic_JJ network_NN ,_, but_CC rather_RB FBA_NNP
        assumes_VBZ that_IN the_DT regulation_NN is_VBZ such_JJ that_IN metabolic_JJ behavior_NN
        is_VBZ optimal_NN ._. This_DT assumption_NN produces_VBZ results_NNS that_WDT are_VBP
        generally_RB consistent_JJ with_IN experimental_JJ data_NNS ,_, however_RB ,_, this_DT
        assumption_NN is_VBZ only_RB valid_JJ for_IN a_DT system_NN that_WDT has_VBZ evolved_VBN
        toward_IN optimality_NN ._. In_IN mutant_JJ strains_NNS ,_, the_DT regulation_NN of_IN the_DT
        metabolic_JJ network_NN has_VBZ not_RB evolved_VBN to_TO operate_VB in_IN an_DT optimal_NN
        fashion_NN ._. Therefore_RB ,_, the_DT optimal_NN utilization_NN of_IN the_DT mutant_JJ
        metabolic_JJ network_NN does_VBZ not_RB necessarily_RB correspond_VB to_TO the_DT 
        in_IN vivo_NN utilization_NN of_IN the_DT metabolic_JJ
        network_NN ._. Computational_NNP analysis_NN of_IN metabolic_JJ processes_NNS ,_,
        coupled_VBN to_TO an_DT experimental_JJ program_NN may_MD provide_VB valuable_JJ
        information_NN regarding_VBG the_DT regulatory_JJ structure_NN of_IN metabolic_JJ
        networks_NNS ,_, and_CC will_MD provide_VB a_DT challenge_NN for_IN future_JJ
        computational_NN studies_NNS coupled_VBN to_TO highly_RB parallel_JJ
        experimental_JJ programs_NNS ,_, such_JJ as_IN large-scale_JJ mutation_NN studies_NNS
        [_NN 41_CD ]_NN ._.
        Currently_RB ,_, about_IN one-third_NN of_IN the_DT 
        E_NNP ._. coli_NNS open_JJ reading_NN frames_NNS do_VBP not_RB
        have_VB a_DT functional_JJ assignment_NN ._. Thus_RB ,_, the_DT metabolic_JJ network_NN
        studied_VBN here_RB is_VBZ incomplete_JJ and_CC does_VBZ not_RB account_VB for_IN all_PDT the_DT
        metabolic_JJ processes_VBZ carried_VBN out_IN by_IN 
        E_NNP ._. coli_NNS ._. However_RB ,_, we_PRP have_VBP used_VBN the_DT
        biochemical_JJ literature_NN to_TO refine_VB the_DT 
        in_IN silico_NN metabolic_JJ genotype_NN and_CC
        given_VBN the_DT long_JJ history_NN of_IN 
        E_NNP ._. coli_NNS metabolic_JJ research_NN [_NN 20_CD ]_NN ,_, a_DT
        large_JJ percentage_NN of_IN the_DT 
        E_NNP ._. coli_NNS metabolic_JJ capabilities_NNS have_VBP
        likely_RB been_VBN identified_VBN ._. However_RB ,_, when_WRB additional_JJ metabolic_JJ
        capabilities_NNS are_VBP discovered_VBN [_NN 42_CD ]_NN ,_, the_DT 
        E_NNP ._. coli_NNS stoichiometric_JJ matrix_NN can_MD be_VB
        updated_VBN ,_, leading_VBG to_TO an_DT iterative_JJ model_NN building_NN process_NN ._.
        Furthermore_RB ,_, inconsistencies_NNS between_IN the_DT model_NN and_CC
        experimental_JJ data_NNS may_MD help_VB point_VB to_TO unidentified_JJ metabolic_JJ
        functions_NNS ._. Additionally_RB ,_, the_DT 
        in_IN silico_NN analysis_NN can_MD help_VB identify_VB
        missing_VBG or_CC incorrect_JJ functional_JJ assignments_NNS ;_: for_IN example_NN ,_,
        by_IN identifying_VBG sets_NNS of_IN metabolic_JJ reactions_NNS that_WDT are_VBP not_RB
        connected_VBN to_TO the_DT metabolic_JJ network_NN by_IN the_DT mass_NN balance_NN
        constraints_NNS ._.
        The_DT study_NN presented_VBD herein_NN is_VBZ an_DT example_NN of_IN the_DT rapidly_RB
        growing_VBG field_NN of_IN 
        in_IN silico_NN biology_NN ._. It_PRP is_VBZ clear_JJ that_DT
        computer_NN modeling_NN and_CC simulations_NNS must_MD be_VB used_VBN iteratively_RB
        with_IN an_DT experimental_JJ program_NN to_TO continually_RB improve_VB 
        in_IN silico_NN models_NNS and_CC to_TO develop_VB
        systemic_JJ understanding_NN of_IN cellular_JJ functions_NNS ._. Thus_RB ,_, an_DT 
        in_IN silico_NN analysis_NN can_MD be_VB used_VBN to_TO
        define_VB an_DT experimental_JJ program_NN ._. For_IN example_NN ,_, the_DT ability_NN to_TO
        construct_VB well-defined_JJ knockout_NN strains_NNS of_IN 
        E_NNP ._. coli_NNS [_NN 43_CD ]_NN opens_VBZ the_DT possibility_NN
        to_TO critically_RB evaluate_VB the_DT relation_NN between_IN the_DT 
        in_IN silico_NN representation_NN of_IN mutant_JJ
        behavior_NN and_CC the_DT 
        in_IN vivo_NN metabolic_JJ network_NN under_IN
        well-defined_JJ genetic_JJ and_CC environmental_JJ conditions_NNS for_IN
        strategically_RB chosen_VBN genes_NNS ._. This_DT possibility_NN is_VBZ
        particularly_RB timely_JJ ,_, given_VBN the_DT increasing_VBG number_NN of_IN genome_NN
        scale_NN measurements_NNS that_WDT are_VBP now_RB possible_JJ ,_, through_IN 2_CD D_NNP gels_NNS [_NN
        44_CD ,_, 45_CD ]_NN and_CC DNA_NNP array_NN technology_NN [_NN 46_CD ,_, 47_CD ]_NN ._.
      
      
        Conclusions_NNP
        Herein_NNP ,_, we_PRP have_VBP utilized_JJ an_DT 
        in_IN silico_NN representation_NN of_IN 
        E_NNP ._. coli_NNS to_TO study_VB the_DT condition_NN
        dependent_JJ phenotype_NN of_IN 
        E_NNP ._. coli_NNS and_CC central_JJ metabolism_NN gene_NN
        deletion_NN strains_NNS ._. We_PRP have_VBP shown_VBN that_IN a_DT computational_NN
        analysis_NN of_IN the_DT metabolic_JJ behavior_NN can_MD provide_VB valuable_JJ
        insight_NN into_IN cellular_JJ metabolism_NN ._. The_DT present_NN 
        in_IN silico_NN study_NN builds_VBZ on_IN the_DT ability_NN
        to_TO define_VB metabolic_JJ genotypes_NNS in_IN bacteria_NNS and_CC mathematical_JJ
        methods_NNS to_TO analyze_VB the_DT possible_JJ and_CC optimal_NN phenotypes_NNS that_IN
        they_PRP can_MD express_VB ._. These_DT capabilities_NNS open_VB the_DT possibility_NN
        to_TO perform_VB 
        in_IN silico_NN deletion_NN studies_NNS to_TO help_VB
        sort_VB out_RP the_DT complexities_NNS of_IN 
        E_NNP ._. coli_NNS mutant_JJ phenotypes_NNS ._.
      
    
  
